Marksans Pharma Ltd. — Call Transcript 2025

Oct 31, 2025

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [110 x 18] intentionally omitted <==

October 31, 2025

BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai – 400001. Bandra (East), Mumbai – 400051. Scrip Code: 524404 Symbol: MARKSANS

Subject: Intimation of schedule for Q2FY26 Earnings Conference Call

Dear Sir/Madam,

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled a conference call for analysts and investors on Friday, November 14, 2025 at 05:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2025.

The details and schedule with respect to the conference call are enclosed herewith. The presentation along with the audio recording of the call and the transcript will be hosted on the Company’s website at https://www.marksanspharma.com/earnings-call-transcripts.html

We request you to take the aforesaid on your records.

Thanking you.

Yours faithfully, For Marksans Pharma Limited

Digitally signed by H H PANIGRAHI PANIGRAHI Date: 2025.10.31 11:33:00 +05'30'

Harshavardhan Panigrahi Company Secretary

Encl: As below

==> picture [5 x 74] intentionally omitted <==

==> picture [72 x 15] intentionally omitted <==

==> picture [93 x 15] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [126 x 83] intentionally omitted <==

Marksans Pharma Ltd

Q2FY26 Earnings Call CIN: L24110MH1992PLC066364 Friday, 14 November 2025 at 17:00 hrs (IST)

DAM Capital Advisors Ltd invites you to Marksans Pharma Ltd’s post results conference call

Marksans Pharma Ltd’s Management Speakers

Mr. Mark Saldanha – Founder, Chairman and Managing Director Mr. Jitendra Sharma – Chief Financial Officer

Call Leaders

Nitin Agarwal – Analyst, DAM Capital Advisors Ltd

Dial-in Details

Universal access : +91 22 6280 1384, +91 22 7115 8285 (accessible from all networks and countries)

Diamond passcode link : click here

International dial-in

	Hong Kong	Singapore	UK	USA
	19:30 (HKT)	19:30 (SGT)	12:30 (BST)	07:30 (EDT)
Toll free	800964448	8001012045	08081011573	18667462133

*Please dial-in at least 5-10 minutes prior to the schedule to get connected to the call in time

For further information please contact

Nitin Agarwal / Payal Shah

DAM Capital Advisors Limited

 : +91 22 4202 2568 / 2638

 nitin.a@damcapital.in / payal@damcapital.in